Stryker Total Assets 2010-2025 | SYK

Stryker total assets from 2010 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Stryker total assets for the quarter ending March 31, 2025 were $46.006B, a 16.76% increase year-over-year.
  • Stryker total assets for 2024 were $42.971B, a 7.66% increase from 2023.
  • Stryker total assets for 2023 were $39.912B, a 8.21% increase from 2022.
  • Stryker total assets for 2022 were $36.884B, a 6.51% increase from 2021.
Stryker Annual Total Assets
(Millions of US $)
2024 $42,971
2023 $39,912
2022 $36,884
2021 $34,631
2020 $34,330
2019 $30,167
2018 $27,229
2017 $22,197
2016 $20,435
2015 $16,223
2014 $17,279
2013 $15,743
2012 $13,206
2011 $12,146
2010 $10,895
2009 $9,071
Stryker Quarterly Total Assets
(Millions of US $)
2025-03-31 $46,006
2024-12-31 $42,971
2024-09-30 $43,833
2024-06-30 $39,130
2024-03-31 $39,402
2023-12-31 $39,912
2023-09-30 $38,042
2023-06-30 $37,409
2023-03-31 $36,830
2022-12-31 $36,884
2022-09-30 $35,983
2022-06-30 $36,032
2022-03-31 $36,137
2021-12-31 $34,631
2021-09-30 $34,145
2021-06-30 $33,698
2021-03-31 $33,455
2020-12-31 $34,330
2020-09-30 $32,286
2020-06-30 $31,483
2020-03-31 $29,440
2019-12-31 $30,167
2019-09-30 $26,659
2019-06-30 $26,354
2019-03-31 $25,937
2018-12-31 $27,229
2018-09-30 $22,084
2018-06-30 $21,570
2018-03-31 $22,133
2017-12-31 $22,197
2017-09-30 $21,485
2017-06-30 $21,292
2017-03-31 $20,517
2016-12-31 $20,435
2016-09-30 $20,187
2016-06-30 $20,520
2016-03-31 $19,668
2015-12-31 $16,223
2015-09-30 $15,917
2015-06-30 $16,819
2015-03-31 $16,580
2014-12-31 $17,279
2014-09-30 $17,515
2014-06-30 $17,229
2014-03-31 $16,159
2013-12-31 $15,743
2013-09-30 $14,883
2013-06-30 $14,382
2013-03-31 $14,089
2012-12-31 $13,206
2012-09-30 $12,777
2012-06-30 $12,262
2012-03-31 $12,459
2011-12-31 $12,146
2011-09-30 $12,083
2011-06-30 $11,596
2011-03-31 $11,231
2010-12-31 $10,895
2010-09-30 $10,772
2010-06-30 $10,060
2010-03-31 $10,098
2009-12-31 $9,071
2009-09-30 $8,459
2009-06-30 $7,924
2009-03-31 $7,585
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $149.416B $22.595B
Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $229.711B 27.62
Boston Scientific (BSX) United States $154.351B 38.64
EssilorLuxottica (ESLOY) France $132.057B 0.00
Medtronic (MDT) Ireland $115.083B 16.32
Lonza Group Ag (LZAGY) Switzerland $49.624B 0.00
Haleon (HLN) United Kingdom $44.474B 25.39
ResMed (RMD) United States $37.259B 27.99
Agilent Technologies (A) United States $34.110B 22.24
GE HealthCare Technologies (GEHC) United States $34.090B 16.18
Terumo (TRUMY) Japan $24.459B 31.77
Koninklijke Philips (PHG) Netherlands $23.149B 16.24
Insulet (PODD) United States $20.550B 80.67
Zimmer Biomet Holdings (ZBH) United States $18.570B 11.93
Baxter (BAX) United States $14.641B 10.93
Smith & Nephew SNATS (SNN) United Kingdom $13.157B 0.00
Demant (WILYY) Denmark $8.633B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Bio-Rad Laboratories (BIO) United States $6.825B 23.75
Lantheus Holdings (LNTH) United States $5.747B 14.50
Prestige Consumer Healthcare (PBH) United States $3.776B 16.87
Perrigo (PRGO) Ireland $3.768B 9.55
Haemonetics (HAE) United States $3.683B 16.77
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.395B 28.21
ICU Medical (ICUI) United States $3.220B 23.75
QuidelOrtho (QDEL) United States $1.952B 13.42
LeMaitre Vascular (LMAT) United States $1.900B 42.47
AtriCure (ATRC) United States $1.550B 0.00
Acuren (TIC) United States $1.455B 0.00
Green Thumb Industries (GTBIF) United States $1.374B 30.91
Phibro Animal Health (PAHC) United States $1.278B 16.34
AdaptHealth (AHCO) United States $1.237B 12.56
Neogen (NEOG) United States $1.133B 14.50
BioLife Solutions (BLFS) United States $1.053B 0.00
InMode (INMD) Israel $0.932B 9.39
Kestra Medical Technologies (KMTS) United States $0.792B 0.00
Curaleaf Holdings (CURLF) Canada $0.749B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.680B 0.00
Tilray Brands (TLRY) Canada $0.661B 0.00
Owens & Minor (OMI) United States $0.616B 5.11
Evolus (EOLS) United States $0.613B 0.00
CeriBell (CBLL) United States $0.592B 0.00
Valneva SE (VALN) France $0.517B 0.00
Surmodics (SRDX) United States $0.449B 0.00
SNDL (SNDL) Canada $0.415B 0.00
Capricor Therapeutics (CAPR) United States $0.337B 0.00
VAREX IMAGING (VREX) United States $0.327B 12.02
Sanuwave Health (SNWV) United States $0.310B 0.00
Cresco Labs (CRLBF) United States $0.306B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.304B 0.00
Quanterix (QTRX) United States $0.302B 0.00
Cerus (CERS) United States $0.277B 0.00
Viemed Healthcare (VMD) United States $0.266B 22.40
Aurora Cannabis (ACB) Canada $0.257B 76.33
Sanara MedTech (SMTI) United States $0.257B 0.00
ZimVie (ZIMV) United States $0.249B 11.30
Brainsway (BWAY) Israel $0.231B 61.17
Omeros (OMER) United States $0.230B 0.00
OraSure Technologies (OSUR) United States $0.230B 0.00
Verano Holdings (VRNOF) United States $0.226B 0.00
Biote (BTMD) United States $0.221B 6.22
Canopy Growth (CGC) Canada $0.215B 0.00
Organigram Global (OGI) Canada $0.198B 0.00
High Tide (HITI) Canada $0.195B 0.00
TriSalus Life Sciences (TLSI) United States $0.188B 0.00
Utah Medical Products (UTMD) United States $0.184B 15.00
Vireo Growth (VREOF) United States $0.162B 0.00
Exagen (XGN) United States $0.151B 0.00
FitLife Brands (FTLF) United States $0.123B 15.13
TerrAscend (TSNDF) Canada $0.115B 0.00
Fonar (FONR) United States $0.101B 13.05
MacroGenics (MGNX) United States $0.100B 0.00
Jin Medical (ZJYL) China $0.094B 0.00
Jushi Holdings (JUSHF) United States $0.092B 0.00
Veru (VERU) United States $0.089B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Quipt Home Medical (QIPT) United States $0.083B 0.00
Apyx Medical (APYX) United States $0.074B 0.00
InterCure (INCR) Israel $0.071B 0.00
Agape ATP (ATPC) $0.069B 0.00
Cytosorbents (CTSO) United States $0.066B 0.00
Zynex (ZYXI) United States $0.064B 0.00
ImmuCell (ICCC) United States $0.059B 0.00
Nephros (NEPH) United States $0.040B 54.00
Safety Shot (SHOT) United States $0.040B 0.00
Modular Medical (MODD) United States $0.039B 0.00
Rockwell Medical (RMTI) United States $0.038B 0.00
United-Guardian (UG) United States $0.037B 12.87
Allurion Technologies (ALUR) United States $0.021B 0.00
Flora Growth (FLGC) United States $0.016B 0.00
INLIF (INLF) $0.015B 0.00
Meihua Medical Technologies (MHUA) China $0.014B 0.00
IM Cannabis (IMCC) Canada $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.013B 0.00
Senestech (SNES) United States $0.011B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00